NanoHive Medical
United States
- Woburn, Massachusetts
- 06/08/2024
- Series C
- $7,000,000
NanoHive Medical (formerly HD LifeSciences) created the proprietary, biomimetic Soft Titanium technology, which clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides surgeons and their patients with the ideal features that lead to consistently strong fusion constructs and efficacious clinical experiences.
- Industry Medical Equipment Manufacturing
- Website https://nanohive.com/
- LinkedIn https://www.linkedin.com/company/nanohivemedical/
Related People
Patrick O.Founder
United States -
Greater Boston
Medical Device and Biosurgery executive leader with over 25 years of consistently successful experience at pre-commercial and commercial stages companies. Success in the medical device, orthobiologics, and biomaterials industries with technologies in the orthopedic, spine, neurosurgery, sports medicine, interventional radiology markets. Extensive team-building, executive management, strategy development, sales and marketing management, strategic partnership development, distribution channel development, Board management, start-up, turn around, and fund raising (over $90M) experience.
Deep Blue Medical Advances, Inc. | $5,600,000 | (Apr 22, 2026)
NeoCognition | $40,000,000 | (Apr 22, 2026)
Ideally | $10,000,000 | (Apr 22, 2026)
Monk | $25,000,000 | (Apr 22, 2026)
Reliable Robotics Corporation | $160,000,000 | (Apr 22, 2026)
Humble Robotics | $24,000,000 | (Apr 22, 2026)
Sinai.ai | $1,450,000 | (Apr 22, 2026)
Qualitate | $7,000,000 | (Apr 22, 2026)
Exergy3 Limited | $13,523,900 | (Apr 22, 2026)
Syenta | $26,000,000 | (Apr 22, 2026)
urfuture | $2,299,785 | (Apr 21, 2026)
Ultralight | $9,300,000 | (Apr 21, 2026)